1 year return (CAGR)
3.85%
Inhibikase Therapeutics Inc Exchange (NASDAQ, USD)
IKT
1.62
+0.05 (+3.18%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
23.79%
5 year return (CAGR)
-31.73%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
226.05M
Price/Sales
-
Ent value
205.10M
Price/Book
1.47
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-25.09%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.55 |
| Daily high | 1.63 |
| Daily low | 1.53 |
| Daily Volume | 387K |
| All-time high | 58.80 |
| 1y analyst estimate | 6.00 |
| Beta | 0.96 |
| EPS (TTM) | -0.35 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IKT | S&P500 | |
| Current price drop from All-time high | -97.24% | -0.87% |
| Highest price drop | -98.62% | -56.47% |
| Date of highest drop | 9 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -88.74% | -10.65% |
| Avg time to new high | 734 days | 12 days |
| Max time to new high | 1467 days | 1805 days |
News
